Promotion of medicine is “any activity undertaken by a pharmaceutical company or with its authority which promotes the administration, consumption, prescription, purchase, recommendation, sale, supply or use of its medicine’’. Given the billions of dollars spent during drug development, a pharmaceutical company must be able to make a profit in order to sustain its self, as such; good promotion strategy to market the product is paramount to the success of the company. The promotion of medicine might take several forms, such as journal and direct mail advertising, activities of representatives, the supply of samples, provision of inducements within the legal framework, provision of hospitality for promotional purposes, sponsorship of promotional or scientific meetings and other sales promotion in whatever form. As with medicine promotion, food advertising is also regulated in the EU and the UK, especially on the provision of clear and non-misleading information to consumers.
Mauro Luisetto*, Nili B. Ahmadabadi, K. Edbey Khaled Edbey, L. Cabianca and Oleg Yurevich Llatyshev
Biopharmaceuticals production is based on a GMP system of quality control used for the regulatory scope. Relvant for this role the analytical procedure, specificity and sensibility of the methods to test raw materials but also the final products before commercialization. Aim of this work is to verify the role played by nanolipids on Raman Spettroscopy encapsulating active principle or other substantia unsing different procedure: 1) Destructive and 2) Non destructive technique. This is relevant because regualtory agency authorized ( EMA) for cGMP rules the use also of non destructive methods like RAMAN spettroscopy in various stage of manifacturing drugs ( for raw material and final product).
The present impacts of the Biopharmaceutics Classification System (BCS) and Biopharmaceutics Drug Disposition Classification System (BDDCS) on pertinent scientific advancements are discussed. The detailed study of the dissolution of poorly absorbed BCS class II drugs in nutritive liquids (such milk and peanut oil) and biorelevant media for the precise prediction of the rate and degree of oral absorption is one of the key BCS accomplishments.
Now, it is possible to test brain models, animate the cerebral cortex and cure mental illnesses using constrained electric fields. In terms of interpretation, the plasticity of the brain was investigated using a mouse model of intracortical microstimulation employing acoustoelectric transduction of ultrasonic signals. Deep cerebrum feeling (DBS) treatment, which is similar to neuromodulation, has been shown to be effective in treating drug-safe epilepsy in clinical studies. Because electrical feeling through intracranial terminals can affect electrical transmission inside the brain, transcranial electrical stimulation (tES), which is delivered safely through the scalp, can be used to activate these fields. The advantages of tES include its affordability, versatility and potential at-home applications, which address the rise in human preliminary tests.
A growing body of preclinical evidence suggests that certain cannabinoids, such as cannabidiol (CBD) and its engineered derivatives, may play a role in the myelinating processes. These cannabinoids are also promising small particles that could be developed as a treatment option for a variety of demyelinating conditions, including multiple sclerosis (MS), stroke and traumatic brain injury (TBI), which are three of the most common forms of demyelina Both the phytocannabinoid and its subordinates may be considered potential candidates for clinical use due to the properties shown by CBD and its fascinating human profile. We will summarize the most recent developments in the use of CBD and other cannabinoids as potential future medicines in this survey. It is anticipated that the coordinated effort of central participants, such as essential analysts, clinicians and pharmaceutical organizations, will bring novel treatments to patients, despite the fact that new research is accelerating the interaction for the age of novel medication competitors and distinguishing proof of druggable focuses on.
Many investigations have looked into drug reuse convictions. Although training is not permitted in some types of pharmacy stores, it is nonetheless done elsewhere in the world where the quality of returned prescriptions is determined by visual inspection. One suggestion is to align sensor innovation with prescription packaging as a gauge of their quality under all circumstances. Our goal was to gauge people's opinions about reusing prescription drugs in a survey, regardless of sensor technology or a doctor's commitment to performing a visual check. Two free variables were intended to test the hypothesis that sensors and visual checks would increase in support of convictions for medication reuse in a between-member review.
Clinical outcomes of patients with hematological malignancies have been improved by current hematology treatment options. Also, many new or old anticancer drugs affect the cardiovascular system, causing heart problems like left ventricular failure, cardiovascular breakdown, blood vessel hypertension, myocardial ischemia, cardiovascular musicality problems and QTc prolongation on electrocardiograms. It is essential to become familiar with all aspects of cardiotoxicity and to immediately give these patients the proper consideration because these misunderstandings could jeopardize the substantially improved outcomes of current anticancer treatments. In a similar vein, new and established medications contribute to both primary and secondary prevention of cardiovascular infections. Patients with hematologic malignancies undergoing anticancer medication treatment or hematopoietic immature microorganism transplantation are the focus of this audit, which examines the clinical signs, preventative measures and drug the board of cardiotoxicity.
The drug action has encountered throughout the course of recent years a significant development as far as ideas and items influencing drug specialists as well as the entire wellbeing experts. The characteristics and repercussions of that change were the focus of this investigation. We go over the main factors that led to this change as well as the characteristics of the new pharmaceutical activity, which focuses primarily on the filtrate. We also make people aware of drug-related issues and the need for professional help to find a solution. The idea that this new proposed pharmaceutical intervention model can actually improve benefits on therapeutical effectiveness and save resources is supported by some preliminary findings from an investigation into the aforementioned conditions.
Guidelines for the design of pivotal psychiatric drug trials used in new drug applications are produced by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Who is involved in the development of the guideline and what specific trial design recommendations they provide are unknown. A cross-sectional investigation of the FDA Guidance Documents and the EMA Clinical Efficacy and Safety Guidelines. Results of the study: 1) declared conflicts of interest among members of the guideline committee; 2) the creation of guidelines and the arrangement of the commenting phases; 3) categorisation of partners who remark on draft and last rules as per irreconcilable circumstances ('industry', 'notindustry however with industry-related clashes', 'autonomous', 'indistinct'); and (4) recommendations for the trial design.
The various branches of science are expanding at a breakneck pace and a vast amount of new information is gradually being discovered and incorporated into the existing human knowledge. Without a doubt, pharmaceutical sciences are one of the most dynamic fields of science because their content is derived from a variety of basic and applied researches, such as those in engineering, biochemistry, biology, pharmacology and pharmacotherapy. These explores are intended to comprehend how to foster new medications, upgrade their conveyance to the body and make an interpretation of these coordinated comprehension into new treatments against human infection as well as further developed local area wellbeing.
Community pharmacy is a type of pharmacy that provides healthcare services to individuals within a specific community. These pharmacies are typically located in areas where there is a high demand for healthcare services and are often the first point of contact for patients seeking medical attention. They offer a range of services including dispensing medications, providing medication advice and counselling, health screenings and administering vaccinations.
Uganda National Bureau of Standards is mandated to enforce standards in protection of the public against harmful, dangerous and sub-standard products. The enforcement activities are carried out through market surveillance activities while compliance to the standards is handled by Certification function. For the past five years, the Bureau has registered a progressive increase in the performance of these two functions and therefore it was imperative to examine the impact of surveillance activities on the certification services. Data was collected from UNBS database for the performance of these functions in the past five years. Correlation and regression analyses were applied to examine the associations that exist between market surveillance activities and certification services. The findings revealed that a very strong and positive correlation between market surveillance and certification services (r=0.947). It was revealed that 89.6% of certification services are influenced by market surveillance activities (R Square=0.896).
Sunil Gupta* and Shubham Dawange
Although the intake of caffeine dates back to the time when various civilisations were just beginning, energy drinks (EDs) were only launched about 40 years ago. Since then, both India and Canada have seen an upsurge in the consumption of caffeinated energy drinks (CEDs). It has been contrasted between the regulatory standards in India and Canada for CED marketing permission. This covers the warnings for caffeinated beverages as well as the Recommended Daily Allowance (RDA) amounts for its ingredients. In order to comprehend the licencing process for caffeinated beverages in terms of manufacturing, distribution and sale, new start-ups and manufacturers will benefit from the comparison. The CED FSSAI guidelines are subject to individual interpretation. While the CEDs regulations in Canada are quite simple. Hence, the present review gives the exact information related to registration process of caffeinated beverages in Canada and India. Also, the standards set by Canada and India for energy drinks are mentioned in this review which helps new organisation and start-ups to explore the regulatory requirements for caffeinated energy drinks.
Pharmaceutical Regulatory Affairs: Open Access received 471 citations as per Google Scholar report